One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.esmoop.2024.102724
Copy DOI Journal: ESMO open |  Publication Date: Mar 1, 2024 |
 License type: cc-by-nc-nd |
Affiliation: Sun Yat-sen University Cancer Center, Third Affiliated Hospital of Harbin Medical University, Hubei Cancer Hospital, West China Hospital of Sichuan University, Nanjing University of Chinese Medicine, Wuhan Union Hospital, Renmin Hospital of Wuhan University, First Affiliated Hospital of Xi'an Jiaotong University, Fourth Hospital of Hebei Medical University137MO Phase II study of becotarug (JMT101) combined with osimertinib in patients (pts) with locally advanced or metastatic NSCLC harboring EGFR exon 20 insertion (ex20ins) mutations (BECOME study)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
